发明名称 |
Poly (ADP-ribose) polymerase inhibitor |
摘要 |
Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like. |
申请公布号 |
US9187430(B2) |
申请公布日期 |
2015.11.17 |
申请号 |
US201214361698 |
申请日期 |
2012.12.03 |
申请人 |
CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD. |
发明人 |
Ji Jianxin;Guo Na;Xue Ting;Kang Bingqiang;Ye Xinfa;Chen Xin;Zhang Tao |
分类号 |
C07D237/32;C07D401/14;C07D413/14;A61K31/502;A61K31/5025;C07D401/12;C07D407/14;C07D409/14;C07D417/14 |
主分类号 |
C07D237/32 |
代理机构 |
Jun He Law Offices P.C. |
代理人 |
Jun He Law Offices P.C. ;Zhu James J. |
主权项 |
1. The compound 4-(3-(4-(1-(dimethylamino)cyclopropanecarbonyl) piperazine-1-carbonyl)-4-fluorophenoxy)2H-phthalazin-1-one, pharmaceutically acceptable salt or stereoisomer thereof. |
地址 |
High-Tech Devlopment Zone, Chengdu CN |